 |
 |

Chlamydia pneumoniae Infection: Which Role in Atherosclerosis?
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The study by van der Ven et al1 showed
antibodies to Chlamydia pneumoniae to be significantly
associated with atherosclerosis and renovascular disease in patients with
hypertension and a strongly suspected renal artery stenosis. The specific
IgG or IgA antibodies used in the study, however, do not necessarily distinguish
between persistence of real infections and only a previous contact. Specific
IgG-containing immune complexes for C pneumoniae have
been demonstrated to be more sensitive markers of a real infection.2
Because of these limitations, the authors' data do not really indicate
that the infectious agent plays a direct role in atherosclerosis. The high
prevalence of a seropositivity to C pneumoniae in
patients with atherosclerosis may rather suggest a "bystander activation"
of the immune system.3 Autoreactive T
cells may exist in these subjects, representing a potential reservoir of pathogenic
effectors that, when stimulated by microbial adjuvants, could trigger an autoimmune
phenomenon. The induction of . . . [Full Text of this Article]
|